(Q39381465)

11 September 2017

Topical ketamine gel: possible role in treating neuropathic pain (English)

1 reference

11 September 2017

0 references

Gammaitoni A

1

1 reference

PubMed ID

15101968

11 September 2017

Gallagher RM

series ordinal

2

1 reference

PubMed ID

15101968

11 September 2017

Welz-Bosna M

series ordinal

3

1 reference

11 September 2017

1 March 2000

1 reference

11 September 2017

1 reference

11 September 2017

1

1 reference

11 September 2017

1

1 reference

11 September 2017

97-100

1 reference

Pharmacotherapy of neuropathic pain

11 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2000.00006.X

Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2000.00006.X

Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2000.00006.X

Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2000.00006.X

Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2000.00006.X

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2000.00006.X

Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2000.00006.X

10.1046/J.1526-4637.2000.00006.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

15101968